Compare BFIN & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BFIN | SGMO |
|---|---|---|
| Founded | 1924 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 137.1M | 155.1M |
| IPO Year | N/A | 2000 |
| Metric | BFIN | SGMO |
|---|---|---|
| Price | $12.15 | $0.50 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 7 |
| Target Price | ★ $11.50 | $4.71 |
| AVG Volume (30 Days) | 40.2K | ★ 9.3M |
| Earning Date | 10-30-2025 | 11-06-2025 |
| Dividend Yield | ★ 3.30% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.19 | N/A |
| Revenue | ★ $46,495,000.00 | $32,875,000.00 |
| Revenue This Year | N/A | $1.37 |
| Revenue Next Year | $6.15 | N/A |
| P/E Ratio | $65.23 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.69 | $0.38 |
| 52 Week High | $13.92 | $2.84 |
| Indicator | BFIN | SGMO |
|---|---|---|
| Relative Strength Index (RSI) | 64.25 | 51.55 |
| Support Level | $11.72 | $0.42 |
| Resistance Level | $11.95 | $0.55 |
| Average True Range (ATR) | 0.26 | 0.05 |
| MACD | 0.10 | 0.02 |
| Stochastic Oscillator | 93.60 | 67.23 |
BankFinancial Corp is a full-service, national bank providing banking, financial planning and fiduciary services to individuals, families and businesses in the Chicago metropolitan area and on a regional or national basis for commercial finance, healthcare finance, equipment finance, commercial real estate finance and treasury management business customers. The Bank offers its customers a broad range of loan, deposit, trust and other financial products and services through approximately 18 full-service banking offices located in Cook, DuPage, Lake and Will Counties, Illinois and through its Internet Branch.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.